Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Nov 8, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2018 PForm 4 → | Nov 7, 5:19 pm EST | REPRO MED SYSTEMS INCREPR | Joseph M. Manko Jr. +3Director, 10% Owner | 72,787 | $1.71 | $124,222 | 6,644,068 | +1.11% | plan? |
| Nov 5, 2018 PForm 4 → | Nov 7, 5:07 pm EST | JMP GROUP LLCJMP | Joseph A JolsonCEO, Director, 10% Owner | 13,923 | $4.99 | $69,533 | 4,778,122 | +0.29% | plan? |
| Nov 6, 2018 PForm 4 → | Nov 7, 4:10 pm EST | VIVUS INCVVUS | Mark K OkiChief Financial Officer & CAO | 10,000 | $4.07 | $40,700 | 10,000 | — | plan? |
| Nov 7, 2018 PForm 4 → | Nov 7, 4:36 pm EST | Coeur Mining, Inc.CDE | J Kenneth ThompsonDirector | 5,000 | $4.96 | $24,790 | 112,929 | +4.63% | plan? |
| Nov 5, 2018 PForm 4 → | Nov 7, 8:21 pm EST | LIBERTY ALL STAR GROWTH FUND INC.ASG | Richard Carl RantzowOther | 1,710 | $4.81 | $8,225 | 6,452 | +36.1% | plan? |
| Nov 5, 2018 PForm 4 → | Nov 7, 4:40 pm EST | BioCardia, Inc.BCDA | David McClungChief Financial Officer | 1,600 | $2.56 | $4,102 | 6,200 | +34.8% | plan? |
| Nov 5, 2018 PForm 4 → | Nov 8, 11:10 am EST | IGEN NETWORKS CORPIGEN | Neil Gene ChanCEO, Director | 13,500 | $0.0731 | $987 | 2,333,967 | +0.58% | plan? late |
| Oct 30, 2018 PForm 4 → | Nov 7, 4:02 pm EST | Syndax Pharmaceuticals IncSNDX | Michael L. MeyersSVP, Chief Medical Officer | 200 | $4.79 | $958 | 2,398 | +9.10% | plan? late |
| Nov 2, 2018 PForm 4 → | Nov 7, 4:43 pm EST | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident | 8,000 | $0.0387 | $309 | 26,132,498 | +0.03% | plan? late |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.